ARCHIVES

FDA approves Irinotecan, Days After ODAC Meeting

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

Abortion, Miscarriage Don’t Increase Breast Cancer Risk, NCI Workshop Finds

March 7, 2003

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.

February 13, 2004

House Committee Hits “Earmarks” For diseases; Broder Is Lectured On Occupational Exposures

May 21, 1993

Study Supports Hypothesis On Mastectomy Timing

June 7, 1991

NCI, EORTC Offer Support For Russian Cancer Researchers

April 14, 1995